Fig. 2From: Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activityAssessment of dCK and ENT1 protein expression. Representative western blot analysis of indicated proteins in Z138 sub-clones. CytNS: cytarabine naive sensitive, CytES: cytarabine exposed sensitive, CytR21: cytarabine resistant, CTR: control, B: replicate B. GAPDH was used as loading controlBack to article page